Pulmatrix News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.01.19	AVITA Turns Heads, SENS' Eversense Is "MRI Safe", SCYX Jumps 100% On FURI Data (RTTNews)
18.07.18	CRNX, RUBY To Debut On Nasdaq, CLRB On Watch, PULM To Advance Pulmazole In Q4 (RTTNews)
14.07.18	Week Ahead In Pharmaceuticals - 7 Stocks To Watch (RTTNews)
07.07.18	Week Ahead In Pharmaceuticals - Stocks To Watch (RTTNews)
13.06.18	Pulmatrix Announces Publication of Results from a Phase 1 Pharmacodynamic Study of PUR0200 in COPD Patients (PR Newswire)
11.06.18	Will These Biotech Stocks Soar Or Slump This Month? (RTTNews)
07.06.18	Pulmatrix Announces Approval of Proposals Submitted to Company's Stockholders (PR Newswire)
17.05.18	Pulmatrix selected to present company profile at the 2018 Respiratory Innovation Summit in San Diego (PR Newswire)
11.05.18	Pulmatrix Reports Q1 2018 Results (PR Newswire)
15.03.18	Data Wrecks EARS, NTLA's Q4 Results Miss Expectations, SNSS On Watch (RTTNews)
13.03.18	Pulmatrix Reports 2017 Financial Results; Provides 2018 Outlook on Pulmonary Disease Pipeline (PR Newswire)
12.02.18	Pulmatrix Announces First Subject Dosed in Phase 1 Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole (PR Newswire)
24.01.18	Pulmatrix Will Present Pulmazole Preclinical Data at the 8th Advances Against Aspergillosis Conference to be Held February 1 - 3, 2018 (PR Newswire)
22.01.18	Pulmatrix Announces Acceptance of a Clinical Trial Application in Europe for Pulmazole - an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole (PR Newswire)
09.11.17	Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials (PR Newswire)
31.10.17	Pulmatrix Presents at the North American Cystic Fibrosis Conference (PR Newswire)
30.10.17	Pulmatrix Appoints Dr. James Roach as Chief Medical Officer (PR Newswire)
18.10.17	KMH Integration Launches "Center of Expertise" to Serve Converging IT and Broadcast Technology Market (PR Newswire)
03.10.17	Pulmatrix Antifungal Drug Candidate Receives a Second "Qualified Infectious Disease Product" (QIDP) Designation from the FDA (PR Newswire)
21.09.17	Pulmatrix to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017 (PR Newswire)
20.09.17	Pulmatrix Receives Key Patents on its Inhaled Drug Delivery Technology and its COPD Drug (PR Newswire)
11.09.17	Transition Networks Launches Gigabit Ethernet PoE+ Media Converters with Small Form-Factor Pluggable Optics (PR Newswire)
08.09.17	Pulmatrix to Present at the Rodman & Renshaw Global Investment Conference on September 11, 2017 (PR Newswire)
06.09.17	Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc (PR Newswire)
06.09.17	Vectura H1 Loss Widens; Announces VR410 Deal With Pulmatrix - Quick Facts (RTTNews)
06.09.17	INSM Breathes Easy, XOMA Rises On Analyst Upgrade, CLLS Down On Clinical Hold (RTTNews)
05.09.17	Pulmatrix Receives Award from Cystic Fibrosis Foundation Therapeutics to Support Development of PUR1900 for the Treatment of Pulmonary Fungal Infections (PR Newswire)
24.08.17	Daily Technical Summary Reports on Biotech Stocks -- Paratek Pharma, Pulmatrix, Verastem, and Biostage (PR Newswire)
04.08.17	Pulmatrix Provides 2017 Company Year-to-Date Highlights and Q2 2017 Updated Financials (PR Newswire)
02.08.17	Gainers & Losers Of August 1: OXFD, ENZY, ZYNE, GERN, ACRX... (RTTNews)
17.07.17	Technical Reports on Biotech Equities -- Amicus Therapeutics, Pulmatrix, Amgen, and Bioverativ (PR Newswire)
13.06.17	Pulmatrix Licenses Novel Drug Candidates from RespiVert Ltd., a wholly owned subsidiary of Janssen Biotech, Inc. (PR Newswire)
13.06.17	Technical Reports on Biotech Equities -- Amgen, Pulmatrix, Argos Therapeutics, and Bioverativ (PR Newswire)
18.05.17	Gainers & Losers Of May 17: SNDX, PULM, PBYI, CNCE, XLRN... (RTTNews)
05.05.17	Pulmatrix Reports Q1 2017 Financial Results (PR Newswire)
03.05.17	Pulmatrix Appoints Ted Raad, MBA, as Chief Business Officer (PR Newswire)
27.03.17	Pulmatrix Adds Two Top Fungal Infection Experts to its Scientific Advisory Board (PR Newswire)
22.03.17	Biotechs Focus on Improving Cancer Pain Management for Enhanced Patient Care (PR Newswire)
22.03.17	Biotechs Focus on Improving Cancer Pain Management for Enhanced Patient Care (PR Newswire)
22.03.17	Gainers & Losers Of Mar.21: PULM, AST, GNMX, AXSM, LJPC... (RTTNews)
21.03.17	Pulmatrix Receives European Patent for its Inhaled Drug Delivery Technology (PR Newswire)
21.03.17	Gainers & Losers Of Mar.20.: ESPR, NKTR, CTMX, CERU, GNMX... (RTTNews)
16.03.17	Gainers & Losers Of Mar.15: CERU, CPRX, ARNA, AKAO, GNCA... (RTTNews)
15.03.17	Gainers & Losers Of Mar.14: CVRS, OCX, OFIX, PETX, AMPH... (RTTNews)
10.03.17	Pulmatrix Reports 2016 Financial Results; Provides 2017 Outlook on Pulmonary Disease Pipeline (PR Newswire)
10.03.17	Technical Reports on Biotech Stocks -- Bioverativ, Pulmatrix, PharmAthene, and Zosano Pharma (PR Newswire)
07.02.17	Trump's Intentions to Streamline Drug-Approval Process Fueling Biotech Optimism (PR Newswire)
07.02.17	Trump's Intentions to Streamline Drug-Approval Process Fueling Biotech Optimism (PR Newswire)
07.02.17	Gainers & Losers Of The Day: PULM, AQB, GALE, PETX, KTOV... (RTTNews)
06.02.17	The Biotech Market Grows as Demand for New Therapeutics Increases (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pulmatrix Inc

Aktien Top/Flop

Meistgelesene Nachrichten